Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Smith & Nephew to Buy ArthroCare for $1.7 Billion in Cash
Bloomberg
Monday, February 3, 2014 - 11:04am
tags:
Smith & Nephew, ArthroCare, M&A, devices
Galena, Free Fentanyl Samples and the 'Zombie Apocalypse'
TheStreet.com
Monday, February 3, 2014 - 11:02am
tags:
Galena Biopharma, Fentanyl, Abstral, samples
Merck gets buyout interest for consumer health unit: sources
Reuters
Monday, February 3, 2014 - 11:00am
tags:
Merck, M&A, consumer health, Reckitt Benckiser, Procter & Gamble
3 Newsworthy Biotech Stocks: BioDelivery, CytRx, TG Therapeutics
Wall St Cheat Sheet
Monday, February 3, 2014 - 10:55am
tags:
BioDelivery Sciences, TG Therapeutics, CytRx
WSJ: Scientist's lawsuit accuses AstraZeneca of fudging Brilinta study
Fierce Pharma
Monday, February 3, 2014 - 10:48am
tags:
Brilinta, AstraZeneca
Overlooked Advanced Wound Care Market Catches Attention of Healthcare Analysts, Investors
Forbes
Monday, February 3, 2014 - 10:47am
tags:
wound care, Derma Sciences
Auspex Pharmaceuticals IPO More Auspicious Than It Sounds
Seeking Alpha
Monday, February 3, 2014 - 10:44am
tags:
Auspex Pharmaceuticals, IPOs, chorea, SD-809
Will Gilead (GILD) Disappoint This Earnings Season?
Motley Fool
Monday, February 3, 2014 - 10:43am
tags:
Gilead Sciences, earnings
Oramed's Oral Insulin Pill Data 'Completely Worthless'
TheStreet.com
Monday, February 3, 2014 - 9:41am
tags:
Oramed Pharmaceuticals, oral insulin, diabetes, ORMD-0801
What Does Dendreon Corporation's Fourth Quarter Mean For Investors?
Motley Fool
Monday, February 3, 2014 - 9:38am
tags:
Dendreon, Provenge
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Monday, February 3, 2014 - 9:35am
tags:
biotech, IPOs, Amgen, Ariad Pharmaceuticals, Regeneron
Biogen's TECFIDERA approved in the European Union
Yahoo/Fly on the Wall
Monday, February 3, 2014 - 9:30am
tags:
Biogen, Tecfidera, Europe, MS, multiple sclerosis
AstraZeneca Wins One Battle, But Loses Another (And Perhaps the War) on SYMBICORT Patent Term Extension
FDA Law Blog
Monday, February 3, 2014 - 9:26am
tags:
Symbicort, AstraZeneca, patents
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Fierce Pharma
Monday, February 3, 2014 - 9:23am
tags:
Valeant Pharmaceuticals, M&A, Precision Dermatology
Forest Labs completes $2.9B acquisition of Aptalis
Yahoo/Fly on the Wall
Monday, February 3, 2014 - 8:54am
tags:
Aptalis, Forest Labs, M&A
Bristol-Myers Squibb Completes Previously Announced Sale of Global Diabetes Business to AstraZeneca
Yahoo
Monday, February 3, 2014 - 8:52am
tags:
M&A, diabetes, Bristol-Myers Squibb, AstraZeneca
Ablynx agrees Merck cancer deal worth up to 1.7 billion euros
Yahoo/Reuters
Monday, February 3, 2014 - 8:50am
tags:
Ablynx, Merck, immunotherapy
Given Imaging gets FDA clearance for colon camera pill
Yahoo/Reuters
Monday, February 3, 2014 - 8:49am
tags:
FDA, Given Imaging, devices, colon camera pill, PillCam
Ranbaxy's empty promises
CNN Money
Monday, February 3, 2014 - 8:33am
tags:
Ranbaxy, drug manufacturing, India
Lupin's net profit beats forecast on generic launches
Yahoo/Reuters
Monday, February 3, 2014 - 8:32am
tags:
earnings, generics, Lupin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.